Nigeria’s first attempt to subsidise the high cost of cancer treatment is stumbling barely two years after the Federal Government launched the promising scheme.
The Chemotherapy Access Partnership (CAP), which promises a 50 percent slash on the cost of 16 priority cancer drugs and chemotherapy
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
